Beta Bionics (BBNX) CEO Saint Sean Sells 16,867 Shares

What Happened Saint Sean, President & CEO and a director of Beta Bionics (BBNX), sold 16,867 shares on September 2, 2026. The reported proceeds were about $322,381 (sale price reported as $19.11 per share; weighted average $19.1131). This was a sale (code S) and was described in the filing as done to cover tax withholding obligations associated with the vesting of restricted stock units — a routine, non-speculative reason for an insider sale.

Key Details

• Transaction date: 2026-09-02; Form 4 filed: 2026-09-03 (timely filing).
• Shares sold: 16,867; reported price: $19.11/share; weighted average $19.1131; price range $18.89–$19.545. Full per-price breakdown available upon request (per footnote).
• Reported proceeds: ≈ $322,381.
• Reason given: sale to cover tax withholding related to RSU vesting (footnote F1).
• Shares owned after transaction: not specified in the provided filing excerpt.
• Transaction type: Sale (S). Filing does not indicate a 10b5-1 plan or other trading arrangement.

Context Sales to cover taxes on vested restricted stock units are common and usually reflect routine tax obligations rather than a view on company outlook. For investors, purchases by insiders generally carry more informational weight than routine withholding sales.